Added to YB: 2025-01-21
Pitch date: 2025-01-19
PFE [bullish]
Pfizer Inc.
+4.8%
current return
Author Info
Investing Lawyer is documenting the process of building an investment portfolio producing monthly (net) passive income of 1,000 euros. Sign up for the newsletter.
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$146.5B
Pitch Price
$24.67
Price Target
35.00 (+35%)
Dividend
6.67%
EV/EBITDA
7.56
P/E
14.98
EV/Sales
3.09
Sector
Pharmaceuticals
Category
dividend
Recent Stock Investment - Pfizer Inc.
PFE: Global pharma giant, 180+ countries. Revenue peaked at $100.3B in 2022 due to COVID-19 products, now normalizing. 2024-25 est. $61-64B. Strong product portfolio, heavy R&D investment. Faces patent expirations, regulatory risks. 6% dividend yield, 64% payout ratio. Price target $35, currently $26.
Read full article (6 min)